Partner
Giuliano Marostica
MANAGING PARTNER, TCG Crossover
- Firm
- TCG Crossover
- Title
- MANAGING PARTNER
- Role
- Managing partner
- Known as
- Investor
Claim, correct or request removal
Record updated 17 September 2026
About
Prior to joining TCGX, Giuliano was an Associate at Great Point Partners, where he focused on public investments in therapeutics companies. Prior to joining Great Point Partners, he was an analyst in the Healthcare Investment Banking group at Citigroup. Giuliano graduated magna cum laude with a BSc in Biomedical Engineering from Brown University. Giuliano has led investments in CG Oncology (NASDAQ: CGON, Jan 2024 IPO), Chinook (acquired by Novartis), Cymabay (acquired by Gilead), Inhibrx (acquired by Sanofi), and Madrigal (NASDAQ: MDGL).
Is this you? Remove my profile
Loading relationship preview